วีดีโอ

Newcells company video - short

Newcells Career video

Dr Mike Nicholds - Newcells Offerings

Creatinine Clearance published paper

Dr Mike Nicholds - How Newcells Works With Clients

Dr Mike Nicholds - About the company

Discover more about our lung platform and how we can accelerate your pre-clinical research.

Exploring the innovation behind our lung platforms

Find out more about our retinal model capabilities at Newcells

An explanation of our MPS Flow technology which can be used for a myriad of different applications.

Explaining about the goals of the retina team and our models,

 IPSC-derived retinal organoids are an emerging in vitro tool for various applications  They have a potential of being used in efficacy and safety screens of new compounds and for disease modelling applications  They are increasingly showing utility in gene therapy applications and can be used for testing novel gene therapy vectors and investigating optimal doses, therapeutic potential and s...

Newcells offers a fast and reliable FMT assay to evaluate the efficacy of anti-fibrotic compounds using high-content imaging. This customisable, high-throughput assay is well suited to compound screening for small molecules targeting lung fibrosis. In the fibrotic lung normal repair processes are defective.

Revival of aProximate™ Assay Ready Plates

Newcells retinal organoids as an in vitro tool for preclinical testing of gene therapy vectors

Kidney as a Target: The Important Role of SLCs (Sodium Linked Co-Transporters)

Newcells Retinal Organoids with our Senior Scientist Dr Carolina Gándara

Newcells Retinal Organoids with our Associate Scientist George Buchanan

Why do iPSCs have the potential to change drug discovery?

Why should Newcells be considered as a partner of choice in drug discovery?

How to unpack and plate Retinal Organoids upon delivery

Newcells Tour

NIH/NEI 3D-ROC Sponsor Webinar

The kidney as a therapeutic target: Targeting Therapeutics to the Proximal Tubule

Retinal Organoids as an Emerging Tool for Drug Discovery

How Newcells retinal organoids could be used in ophthalmic retinopathy research

A human iPSC-derived model of SARS-CoV-2 infection and pathogenesis in the lung

Reducing compound attrition by predicting renal tubular toxicity with in vitro PTEC models

Human induced pluripotent stem cell (hiPSC)-derived retinal model containing microglial cells